You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Merck & Co., Inc. is a multinational, research‑driven biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines, vaccines, biologic therapies and animal health products. It operates within the healthcare sector, specifically the pharmaceuticals and biotechnology industry, serving patients, health systems and veterinarians worldwide. The firm is known for its leading oncology drug Keytruda, a broad portfolio of vaccines such as Gardasil, and a substantial animal health business, giving it a strong global market position among the world’s largest pharmaceutical companies.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q3 FY26 | Oct 29, 2026 | — |
| Q2 FY26 | Aug 4, 2026 | -$0.13 |
| Q1 FY26 | Apr 30, 2026 | -$1.28 |
| Q4 FY25 | Feb 3, 2026 | $2.04 |
| Q3 FY25 | Oct 30, 2025 | $2.58 |
Stay ahead of MRK earnings
Get reminders ahead of MRK's next earnings report, so you always know when results are coming.